Cw. Oettinger et al., THE EFFECT OF UREMIA ON TUMOR-NECROSIS-FACTOR-ALPHA RELEASE AFTER AN IN-VITRO WHOLE-BLOOD ENDOTOXIN CHALLENGE, Journal of the American Society of Nephrology, 4(11), 1994, pp. 1890-1895
Uremia has been associated with immunologic aberrations, including ane
rgy, increased susceptibility to infections, and reduced phagocytic ac
tivity of polymorphonuclear leukocytes. In this study, cytokine releas
e in uremic and nonuremic blood after in vitro endotoxin stimulation w
as studied. Blood from nonuremic controls, chronic renal failure patie
nts not on dialysis, and chronic hemodialysis patients predialysis and
postdialysis was spiked with 10 ng/mL of Escherichia coli endotoxin a
nd incubated for 2 and 26 h. Plasma tumor necrosis factor-alpha (TNFal
pha) concentrations were determined by ELISA after each incubation per
iod. To further study which uremic blood component may be responsible
for enhanced release of TNFalpha, plasma and cellular components of ch
ronic renal failure patients and controls were switched and then given
an in vitro endotoxin stimulation (1 ng/mL). It was found that (1) TN
Falpha release is enhanced by uremia and is exacerbated with progressi
ve declines in renal function, (2) enhanced TNFalpha release is relate
d to a blood cellular phenomenon induced by uremia, and (3) enhanced T
NFalpha release in hemodialysis patients is associated with a prolonge
d stimulation and/or reduced plasma elimination of TNFalpha.